Brief: Establishment Labs Announces Japanese Regulatory Approval And Reimbursement For Motiva Implants
10/11/2022 15:12
Nov 10 (Reuters) - Establishment Labs Holdings Inc
ESTA.O :
* ESTABLISHMENT LABS ANNOUNCES JAPANESE REGULATORY APPROVAL
AND
REIMBURSEMENT FOR MOTIVA IMPLANTS AND THE MOTIVA FLORA TISSUE
EXPANDER FOR USE IN POST-MASTECTOMY RECONSTRUCTION
Source text for Eikon: ID:nBw47243ka
Further company coverage: ESTA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Establishment Labs Holdings
See all newsU.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Establishment Labs gains on US FDA approval for more Motiva implant sizes
Brief: Establishment Labs Receives FDA Approval For Additional Sizes Of Motiva Implants
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp